Disease | carcinoma, squamous cell |
Comorbidity | C0001418|adenocarcinomas |
Sentences | 18 |
PubMedID- 21198294 | When tumor types were considered, there were more cpla2alpha positive adenocarcinomas compared with squamous cell carcinomas (17 of 36 adenocarcinomas (47%) vs. |
PubMedID- 24752945 | Although the levels were higher in squamous cell carcinomas compared with adenocarcinomas, the medians were not statistically significant (ercc1: p = .16; rrm1: p = .72). |
PubMedID- 21116241 | In addition, the genes have higher sensitivity (91.67%) in diagnosis of lung adenocarcinomas compared with squamous cell carcinomas (82.35%) (p<0.05). |
PubMedID- 21157449 | For the brca1, as the expression values were significantly higher in squamous cell carcinomas in comparison with the adenocarcinomas (p=0.001), the cutoff values were calculated according to median expression levels in each group of squamous and non-squamous histology. |
PubMedID- 21198279 | In first months, survival was the same in both pathology types, but because of the higher stages of squamous cell carcinomas in comparison with adenocarcinomas, their overall rate was lower. |
PubMedID- 23086271 | squamous cell carcinomas are associated with cigarette smoking, adenocarcinomas may be found in patients who have never smoked. |
PubMedID- 24436270 | Results: tnfsf13 expression was significantly higher in lung adenocarcinomas compared with squamous cell carcinomas (p = .022). |
PubMedID- 26137150 | The results revealed that the expression of aqp5 was significantly higher in adenocarcinomas compared with squamous cell carcinomas (p=0.002). |
PubMedID- 21263248 | Accurate classification of nonsmall cell lung cancers is of paramount clinical relevance, as novel chemotherapeutic agents show different efficacy in adenocarcinomas (adcs) compared with squamous cell carcinomas (sqccs). |
PubMedID- PMC4070603 | The majority of tumours were adenocarcinomas, with squamous cell carcinomas accounting for approxiamately third of cases. |
PubMedID- 22694804 | Although a median number of one peak was sufficient, the loo auc reached only a value of 0.81. a median number of 1 peak was needed to construct a model that was able to differentiate squamous carcinomas with adenocarcinomas (auc 0.88), 4 peaks to differentiate between squamous and adenosquamous carcinomas (auc 0.85), 1 peak to differentiate between adenocarcinomas and adenosquamous carcinomas (auc 0.94), and 3 peaks to predict recurrence (auc 0.92). |
PubMedID- 21283576 | Furthermore, both dubs were more frequently expressed in lung squamous cell carcinomas (ssc), compared with adenocarcinomas (ac). |
PubMedID- 26118612 | Additionally, we assessed if n-stage differs for squamous cell cancers compared with adenocarcinomas and if neoadjuvant therapy alters these results. |
PubMedID- 20563252 | The loss-of-gprc5a signature was prevalent in human lung adenocarcinomas compared with squamous cell carcinomas or normal lung. |
PubMedID- 22710677 | In men, around 40% of oesophageal cancers are adenocarcinomas, with squamous cell carcinomas accounting for ∼20% of cases; this pattern is reversed in women (20% adenocarcinomas and 40% squamous cell carcinomas). |
PubMedID- 25954561 | Common malignancies arising from the minor salivary glands include, in order of appearance, adenoid cystic carcinoma, mucoepidermoid carcinoma, and adenocarcinoma with adenocarcinomas representing 20–25% of all malignant salivary gland tumors in the tongue [4]. |
PubMedID- 21532835 | Another important tumor suppressor gene is lkb1, whose loss-of-function mutation/deletion is observed in 30% lung adenocarcinomas and 20% of squamous cell carcinomas [33, 34]. |
PubMedID- 19900972 | Another important tumor suppressor gene is lkb1, whose loss-of-function mutation/deletion is observed in ∼30% lung adenocarcinomas and 20% of squamous cell carcinomas (6,7). |
Page: 1